Charles Schwab Investment Management Inc Nemaura Medical Inc. Transaction History

Charles Schwab Investment Management Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$4.7 - $16.7 $67,952 - $241,448	-14,458 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.75 - $15.38 $68,675 - $222,364	14,458 New	14,458 $134,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $723K
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.